Summary: Gene expression alterations and potentially underlying gene copy number mutations can be measured routinely in the wet lab, but it is still extremely challenging to quantify impacts of altered genes on clinically relevant characteristics to predict putative driver genes. We developed the R package regNet that utilizes gene expression and copy number data to learn regulatory networks for the quantification of potential impacts of individual gene expression alterations on userdefined target genes via network propagation. We demonstrate the value of regNet by identifying putative major regulators that distinguish pilocytic from diffuse astrocytomas and by predicting putative impacts of glioblastoma-specific gene copy number alterations on cell cycle pathway genes and patient survival. Availability and implementation: regNet is available for download at https:/
Introduction
Gene expression alterations play a central role in many complex genetic diseases. Molecular alterations such as DNA copy number mutations can trigger expression changes of directly affected genes that further influence the expression of other genes (Hastings et al., 2009; Henrichsen et al., 2009) . Typically, many genes (hundreds or even thousands) are differentially expressed between disease and healthy samples. This still puts great challenges on the identification of potential key disease drivers. Standard statistical tests only allow to identify frequently altered genes, but contributions of individual sample-specific gene expression alterations on clinically relevant signatures cannot be quantified routinely so far. Generally, networkbased analyses represent promising strategies to overcome this (Hofree et al., 2013; Leiserson et al., 2015; Seifert et al., 2016) .
Here, we present the R package regNet that utilizes gene regulatory networks to quantify impacts of gene-specific expression changes on clinically relevant signature genes. regNet propagates expression changes through networks. Thereby it becomes possible to predict the impact of alterations of specific genes (e.g. mutations) on other, disease-related genes. The mathematical framework behind regNet has been described in great detail along with in-depth validation studies in Seifert et al. (2016) . The basic regNet workflow is illustrated in Figure 1a . First, regNet learns a regulatory network from a large collection of paired gene expression and copy number profiles. Next, regNet utilizes this network to quantify impacts of sample-specific gene expression changes (source genes, e.g. differentially expressed genes with underlying copy number mutations in a tumor specified by the user) on other clinically relevant target genes (e.g. known disease markers) using network propagation. This enables to identify potential key drivers. regNet enables user-friendly access to the network inference algorithm and the network propagation algorithms described in Seifert et al. (2016) .
After providing details to the implementation, we demonstrate the basic usage and value of regNet in two case studies. First, we analyze the potential interplay of transcription factors that were differentially expressed between pilocytic and diffuse astrocytomas suggesting that underexpression of TBR1 may contribute to increased malignancy of diffuse astrocytomas. Next, we predict potential impacts of glioblastoma-specific gene copy number mutations on cell cycle pathway genes and show that tumor-specific gene copy number mutations enable to distinguish between short and long survival.
Implementation
regNet is divided into four main modules enabling data loading, network inference, network-based predictions of gene expression levels, and network propagation. regNet uses a fixed folder structure to enable a user-friendly storage and loading of results. A comprehensive summary about the underlying mathematical models is given in Text S1. Detailed information about the individual modules and the fixed folder structure are provided in Text S2. A basic demonstration of regNet code usage is outlined in Text S3.
Data loader
regNet requires gene expression profiles and corresponding gene copy number profiles as input data for network inference, network predictions and network propagation. regNet can handle tabdelimited datasets with a fixed column-structure. regNet also allows to transform datasets to apply a learned network for the analysis of . Paired gene expression and copy number data are loaded (data loader) and used to learn a regulatory network (network inference) followed by testing the predictive power of the network on different samples (network validation) and the quantification of impacts (network propagation) of sample-specific gene expression alterations (source genes, e.g. differentially expressed genes with underlying copy number mutations in a tumor specified by the user) on user-defined target genes (e.g. clinically relevant signature genes). (b) Out-degree distribution of TF network considering activator (red) and inhibitor (blue) links. (c) Correlations between TF network predicted and originally measured gene-specific expression levels of three independent astrocytoma test cohorts (GBM, LGG, PA) in comparison to average predictions obtained by ten random networks of the same complexity (Random). (d) Average impacts of major regulators on other TFs comparing the learned (orange) TF network to 100 random networks of the same complexity (grey). (e) Predictive power of the learned cancer cell line network on glioblastoma patients for different network instances. The network instance that only considers the most relevant links (green) is significantly better than the instance that considers all learned links (red) and than random networks of the same complexity (grey). (f) Genome-wide characterization of patient-specific differentially expressed genes with directly underlying gene copy number mutations on cell cycle pathway genes for a selected long-lived glioblastoma patient (TCGA-06-6693). Shown are relative average impacts that can be inhibitory (negative impact score) or activating (positive impact score) for underexpressed genes affected by deletions (green) or overexpressed genes affected by amplifications (red). (g) Kaplan-Meier curve distinguishing short from long-lived glioblastoma patients utilizing patient-specific survival impact scores new datasets with different numbers of genes than the initial dataset that was used to learn the network. This is done by removing additional genes and by setting expression measurements of missing genes to zero (no contribution to analysis).
Network inference
regNet splits the global network inference problem into independent gene-specific sub-network inference tasks. regNet models the expression of each gene as a linear combination of its own copy number and the expression of other putative regulators. A detailed description of the underlying mathematical model and in-depth validation studies were done in Seifert et al. (2016) . See Text S1 for an overview of the underlying mathematical model. Lasso (least absolute shrinkage and selection operator) regression (Tibshirani, 1996) followed by a significance test for lasso (Lockhart et al., 2014 ) is used to learn for each gene those predictors (gene copy number and/or expression levels of other genes) that best predict the expression level of the gene in a given dataset. Corresponding FDR-adjusted P-values (Benjamini and Hochberg, 1995) can be used to obtain user-defined network instances. regNet stores all P-values for learned gene-gene associations (links) and enables the user to choose different P-value cutoffs to create and test network instances of variable confidence and complexity. A specific network instance consists of a subset of the links at a user-defined P-value cutoff. Network inference is usually very time-consuming. In order to speed up the computation, network inference can be split across multiple compute cores. Further, random network instances of a learned network can be obtained by degree-preserving network permutations.
Network-based prediction of gene expression levels
In order to evaluate the quality of a previously learned network, regNet can be used to predict the expression levels of genes in a given dataset. regNet quantifies the prediction quality of each individual gene by computing correlations between predicted and originally measured expression levels. See Text S1 for more details. Ideally, this evaluation should be done using an independent test dataset that was not used for network inference. Different instances of a network can be analyzed by setting a global P-value cutoff and a local gene cutoff (excludes genes in close chromosomal proximity as gene-specific predictors, because such predictors may only represent the underlying local DNA copy number instead of potential regulatory dependencies) to only consider the most relevant network links. The obtained gene-specific correlations enable to evaluate the predictive power of the underlying network. regNet stores these correlations and corresponding P-values in a tab-delimited file for further analysis. This functionality is also available for random networks enabling comparisons to baseline models. Further, correlations between predicted and measured expression levels provide the basis to integrate the quality of the predictions of individual genes into the impact computations via the network propagation module (Text S1).
Network propagation
regNet quantifies for a given dataset the impact of individual regulator genes on all other genes utilizing a previously learned network. This algorithm quantifies for each gene pair (a, b) the direct and indirect contribution of gene a on the expression of gene b under consideration of all existing network paths from a to b, the prediction quality of individual genes along the paths, and possibly existing feedback loops. These impact scores can be computed over all patients in a cohort or for each individual patient. regNet can also integrate contributions of genes acting as potential inhibitors or activators for individual patients. This is done by accounting for the sign of effects (activating, positive sign or inhibiting, negative sign) of individual network links. regNet implements different functions to utilize these possibilities (Suppelmentary Table S1 ). The statistical significance of individual impact scores can be determined by comparisons to impact scores obtained under corresponding random networks. This enables to identify those genes that have the greatest impact on user-defined target genes. An overview of the underlying mathematical models is provided in Text S1. Implementation details are given in Text S2. Code usage examples are shown in Text S3. Further details on the impact computation and an in-depth validation are provided in Seifert et al. (2016) .
Application
We demonstrate the basic functionality and the potential of regNet in two case studies.
Identification of hub regulators distinguishing pilocytic from diffuse astrocytomas
We analyzed the potential interplay and activity of transcription factors (TFs) that distinguish pilocytic astrocytomas (PA) in children from diffuse astrocytomas (AS) in adults. This study requires less than ten minutes on a standard computer enabling to become familiar with the basic regNet functionality. Details of individual regNet function calls of this case study are provided in Text S3. We used regNet to learn a putative TF-TF interaction network of 171 TFs based on gene expression and copy number data of 124 different astrocytomas (47 PA and 77 AS samples) from Seifert et al. (2015) . Characteristics of the network are summarized in Figure 1(b-d) and Supplementary Figure S2 . The network contained more putative activator (269 of 341) than inhibitor links (72 of 341) (Fig. 1b) . Only few TFs had more than four outgoing links ( Supplementary Fig.  S2b ). Some of these potential major regulators are known to be involved in the development of the central nervous system (PAX6, THRB, TBR1), cell proliferation (MEOX2), apoptosis (CCNL2), or histone acetylation (RBBP4) (Safran et al., 2010) . We further used the network to predict the expression of genes in three independent cohorts. The network reached a significantly better prediction of gene expression levels than random networks of the same complexity (Fig. 1c, Text S3 ). Finally, we determined which potential major regulators had great impact on other TFs in the network. We found that TBR1 has by far the strongest impact on other TFs (Fig. 1d) . TBR1 is expressed in post-mitotic cells and required for normal brain development (Bulfone et al., 1995) . We found that the expression of TBR1 was clearly reduced in AS compared to normal brain and PA suggesting that TBR1 may contribute to the strongly increased malignancy of AS compared to PA.
3.2 Impacts of glioblastoma gene copy number mutations on cell cycle pathway genes and patient survival
We used regNet to predict glioblastoma-specific gene copy number mutations that influence the expression of cell cycle genes and patient survival. This study required about 6.3 computing hours using 400 cores of a compute server [Bull HPC-Cluster (Taurus), Intel(R) Xeon(R) CPU E5-2680 v3 2.50 GHz, ZIH TU Dresden]. Most time was used for network inference, which generally scales linearly with the number of cores making such a study also feasible on a compute server with less cores. More details to this study are provided in Text S4. We learned a genome-wide transcriptional regulatory network from gene expression and copy number data of 15 811 genes in 768 human cancer cell lines (Barretina et al., 2012) . This network contained much more activator (46 366 of 53 955) than inhibitor (7589 of 53 955) links and 4938 genes had a direct copy number effect. This observation was not unexpected (e.g. synchronous activation of target genes of a TF will lead to activator links). We used this network to predict gene expression of glioblastomas (TCGA, 2008) . In accordance with Seifert et al. (2016) , we found that the predictive power of this network was significantly better than for random networks of the same complexity and a corresponding more complex network that utilized all learned links without filtering for significant links (Fig. 1e, Supplementary Fig. S3, Supplementary Text S4) . Next, we determined the impact of differentially expressed genes with underlying copy number mutations on the expression of cell cycle pathway genes for patients with very short (8 patients: less than 20 days) or very long (10 patients: more than 2000 days) survival. We found that genes with significant impact on cell cycle were not disjoint between short and long-lived patients (Fig. 1f , Supplementary Fig. S4 ). Interestingly, there was a tendency that long-lived patients tend to contain more gene copy number mutations that impact on the expression of cell cycle pathway genes than short-lived patients ( Supplementary Fig. S5 ). Several of these genes play important roles in the regulation of cell growth, migration and proliferation (Text S4). This suggests that some of the observed gene copy number mutations in long-lived patients may counteract fast tumor growth with benefits for patient survival. Finally, we computed the impacts of differentially expressed genes with underlying copy number mutations on known survival signature genes for each of the short and long-lived patients. regNet was able to separate the selected glioblastoma patients into a short and long-lived group (Fig.  1g, Supplementary Fig. S6 ).
Conclusion
regNet predicts the impact of gene expression alterations on userdefined target genes, while accounting for direct and indirect network effects. regNet can identify potential key drivers and quantify combined impacts of altered genes on clinically relevant characteristics. Since network inference and propagation are typically very time and resource consuming for large datasets, we recommend to use regNet on a compute server. regNet currently exploits information contained in gene expression and copy number data for network inference, but the underlying mathematical model is flexible enough to enable the integration of additional omics layers. We finally note that applications of regNet are not necessarily limited to cancer.
